iShares NASDAQ US Biotechnology UCITS ETF (LON:BTEE)
5.74
-0.01 (-0.17%)
May 9, 2025, 4:35 PM BST
LON:BTEE Holdings List
As of May 7, 2025
No. | Symbol | Name | % Weight |
---|---|---|---|
1 | VRTX | Vertex Pharmaceuticals Incorporated | 8.31% |
2 | AMGN | Amgen Inc. | 8.21% |
3 | GILD | Gilead Sciences, Inc. | 7.93% |
4 | REGN | Regeneron Pharmaceuticals, Inc. | 6.90% |
5 | AZN | AstraZeneca PLC | 4.67% |
6 | ALNY | Alnylam Pharmaceuticals, Inc. | 4.09% |
7 | ARGX | argenx SE | 2.28% |
8 | SMMT | Summit Therapeutics Inc. | 2.05% |
9 | BIIB | Biogen Inc. | 1.96% |
10 | SNY | Sanofi | 1.72% |
11 | RPRX | Royalty Pharma plc | 1.62% |
12 | UTHR | United Therapeutics Corporation | 1.58% |
13 | INSM | Insmed Incorporated | 1.41% |
14 | NBIX | Neurocrine Biosciences, Inc. | 1.39% |
15 | ILMN | Illumina, Inc. | 1.38% |
16 | INCY | Incyte Corporation | 1.32% |
17 | BMRN | BioMarin Pharmaceutical Inc. | 1.29% |
18 | EXEL | Exelixis, Inc. | 1.18% |
19 | VTRS | Viatris Inc. | 1.17% |
20 | TEM | Tempus AI, Inc. | 1.12% |
21 | ASND | Ascendis Pharma A/S | 1.11% |
22 | ONC | BeiGene, Ltd. | 1.11% |
23 | MRNA | Moderna, Inc. | 1.06% |
24 | BNTX | BioNTech SE | 1.06% |
25 | MEDP | Medpace Holdings, Inc. | 1.04% |
26 | HALO | Halozyme Therapeutics, Inc. | 0.99% |
27 | ROIV | Roivant Sciences Ltd. | 0.91% |
28 | RVMD | Revolution Medicines, Inc. | 0.80% |
29 | BBIO | BridgeBio Pharma, Inc. | 0.78% |
30 | MDGL | Madrigal Pharmaceuticals, Inc. | 0.75% |
31 | BPMC | Blueprint Medicines Corporation | 0.73% |
32 | JAZZ | Jazz Pharmaceuticals plc | 0.70% |
33 | ADMA | ADMA Biologics, Inc. | 0.64% |
34 | VRNA | Verona Pharma plc | 0.62% |
35 | AXSM | Axsome Therapeutics, Inc. | 0.62% |
36 | IONS | Ionis Pharmaceuticals, Inc. | 0.60% |
37 | ALKS | Alkermes plc | 0.57% |
38 | GH | Guardant Health, Inc. | 0.56% |
39 | NUVL | Nuvalent, Inc. | 0.51% |
40 | RYTM | Rhythm Pharmaceuticals, Inc. | 0.47% |
41 | KRYS | Krystal Biotech, Inc. | 0.45% |
42 | CYTK | Cytokinetics, Incorporated | 0.45% |
43 | PCVX | Vaxcyte, Inc. | 0.43% |
44 | SRPT | Sarepta Therapeutics, Inc. | 0.41% |
45 | SWTX | SpringWorks Therapeutics, Inc. | 0.40% |
46 | AKRO | Akero Therapeutics, Inc. | 0.39% |
47 | PTCT | PTC Therapeutics, Inc. | 0.37% |
48 | RNA | Avidity Biosciences, Inc. | 0.36% |
49 | RARE | Ultragenyx Pharmaceutical Inc. | 0.35% |
50 | CRSP | CRISPR Therapeutics AG | 0.34% |
As of May 7, 2025